Table 1 Correlations of miR-22 expression with the clinicopathological features of EOC

Age, y

<55

46

16

30

0.29

?55

63

39

24

FIGO stage

I-II

61

17

44

0.006

III-IV

48

38

10

Histology

Serous

71

34

37

0.65

Nonserous

38

21

17

Residual tumor size (cm)

<1.0

79

37

42

0.09

?1.0

30

18

12

Grade

Well

31

5

26

0.03

Moderate

43

23

20

Poor

35

27

8

Lymph node metastases

Negative

81

34

47

0.01

Positive

28

21

7

Serum CA125

<319

56

24

32

0.12

?319

53

31

22